Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Gen Dent ; 56(2): 182-5, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18348378

RESUMO

Idiopathic osteosclerosis (IO) typically manifests as an incidentally discovered, well-defined homogenous radiopacity that blends in with the surrounding bone. Once the condition is diagnosed, treatment is neither indicated nor necessary; however, atypical variants of osteosclerosis have been described and may pose a diagnostic and management dilemma for the clinician who encounters them. This case report discusses the differential conditions that should be considered when an atypical variant of IO is encountered. While the diagnosis in this case was fortuitously confirmed by biopsy, routine follow-up is the recommended course of action.


Assuntos
Doenças Mandibulares/patologia , Osteosclerose/patologia , Adulto , Feminino , Humanos , Doenças Mandibulares/complicações , Doenças Mandibulares/diagnóstico por imagem , Doenças Mandibulares/cirurgia , Osteosclerose/complicações , Osteosclerose/diagnóstico por imagem , Osteosclerose/cirurgia , Radiografia , Resultado do Tratamento
2.
Am J Dent ; 20(1): 53-8, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17380809

RESUMO

PURPOSE: Recently, sodium hexametaphosphate has been introduced in dentifrice formulations to aid in the control of extrinsic stain. Two independent studies were conducted to evaluate the stain removal efficacy of a novel 0.454% stannous fluoride and sodium hexametaphosphate dentifrice (Crest Pro-Health) relative to a positive control whitening dentifrice (Colgate Total + Whitening) over a 2-week period in a subject population with pre-existing natural extrinsic stain. METHODS: These studies were randomized, positive-controlled, parallel groups, double-blind, 2-week trials. Each study involved approximately 30 healthy adults with visible stain of the facial surfaces of the 12 anterior teeth. After baseline examination, subjects were randomly assigned to a treatment and instructed to brush unsupervised with the assigned dentifrice at least twice daily as they normally do. Efficacy was evaluated by modified Lobene examination on anterior teeth at baseline and end-of treatment (Week 2). RESULTS: 59 subjects, 29 in Study 1 and 30 in Study 2, were evaluable and included in the Week 2 analyses. Subjects ranged from 21-68 years of age. In each study, the positive control dentifrice statistically significantly (P < 0.0001) reduced stain scores following 2 weeks of brushing with median reductions of 61.9% and 94.4%. Similarly, the experimental 0.454% stannous fluoride and sodium hexametaphosphate dentifrice statistically significantly (P < 0.0001) reduced stain scores by 61.8% and 96.6% following 2 weeks of brushing. The adjusted mean changes between treatment groups did not differ significantly between the two dentifrice groups (P > 0.70 in each study). Both dentifrices were well tolerated. No subject discontinued treatment due to an adverse event.


Assuntos
Dentifrícios/uso terapêutico , Fosfatos/uso terapêutico , Fluoretos de Estanho/uso terapêutico , Clareamento Dental , Descoloração de Dente/terapia , Adulto , Idoso , Misturas Complexas/uso terapêutico , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Poliestirenos/uso terapêutico , Ácido Silícico , Dióxido de Silício/uso terapêutico , Fluoreto de Sódio/uso terapêutico , Dente/patologia , Descoloração de Dente/classificação , Descoloração de Dente/patologia , Cremes Dentais , Resultado do Tratamento , Triclosan/uso terapêutico
3.
Gen Dent ; 55(3): 238-43; quiz 244, 264, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17511370

RESUMO

The rational use of drugs in older persons is a challenging area of clinical practice. The increased incidence of multiple chronic illnesses contributes to disproportionately high use of prescription and over-the-counter (OTC) medications, which in turn leads to more adverse drug events among the elderly. Inadequate nutrition and poor patient compliance also may contribute to the problem. Drug studies that use young adult subjects cannot be extrapolated accurately to apply to the elderly because physiologic changes that occur with age affect the pharmacokinetics and pharmacodynamics of drugs. In addition, therapeutic target concentrations of drugs are impossible to define due to marked interindividual variation in the elderly population. Drugs should be administered to elderly patients only when absolutely necessary. The dosages should be titrated to a clearly defined clinical response and dentists should avoid drugs that are known to be problematic for older adults.


Assuntos
Envelhecimento/fisiologia , Tratamento Farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/metabolismo , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Homeostase/fisiologia , Humanos , Rim/metabolismo , Pessoa de Meia-Idade , Cooperação do Paciente , Preparações Farmacêuticas/metabolismo , Farmacocinética , Farmacologia , Receptores de Superfície Celular/análise , Transdução de Sinais/fisiologia
4.
Am J Dent ; 18 Spec No: 15A-17A, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16178131

RESUMO

PURPOSE: To compare the safety and the antiplaque and antigingivitis efficacy of two oral rinses. METHODS: A randomized, double-blind, parallel groups, single-center study was conducted to evaluate the safety and efficacy of a high bioavailable, alcohol-free 0.07% cetylpyridinium chloride (CPC) rinse (Crest Pro-Health Rinse) and a positive control rinse containing essential oils (EO) and 21.6% ethyl alcohol (Cool Mint Listerine). Seventy-eight healthy adults were enrolled in a modified experimental gingivitis clinical trial. Four weeks before the baseline visit, subjects received a prophylaxis and were instructed to brush twice daily in a manner to approach optimum gingival health. At the end of the 4-week period, subjects were randomly assigned to treatment and instructed to use 20 ml of their assigned product for 30 seconds after brushing twice daily during a 21-day treatment phase. Plaque removal by brushing was prevented during the treatment phase for one mandibular quadrant (experimental gingivitis region) by means of a specially-manufactured tooth shield. Safety and efficacy measurements were obtained at baseline and at the end-of-treatment using the Modified Gingival Index (MGI), Gingival Bleeding Index (GBI), and Modified Quigley-Hein Plaque Index (MQH). At all visits, an oral soft tissue examination was performed for each subject. The efficacy data obtained in the experimental gingivitis region were analyzed with analysis of covariance. RESULTS: Seventy-five subjects completed the study and were included in the data analyses. No statistically significant differences were detected between the two treatment groups for MGI, GBI or MQH measures. Results were similar for shielded interproximal sites. Both treatments were well-tolerated. CLINICAL SIGNIFICANCE: This randomized, controlled comparative clinical trial demonstrated that rinsing twice daily with the experimental alcohol-free 0.07% CPC rinse provides antiplaque and antigingivitis efficacy similar to that of the positive control EO rinse, a recognized antiplaque and antigingivitis mouthrinse that contains alcohol.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Cetilpiridínio/uso terapêutico , Gengivite/prevenção & controle , Antissépticos Bucais/uso terapêutico , Adulto , Placa Dentária/prevenção & controle , Índice de Placa Dentária , Método Duplo-Cego , Combinação de Medicamentos , Hemorragia Gengival/prevenção & controle , Humanos , Mucosa Bucal/efeitos dos fármacos , Índice Periodontal , Segurança , Salicilatos/uso terapêutico , Terpenos/uso terapêutico
5.
Am J Dent ; 18 Spec No: 9A-14A, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16178130

RESUMO

PURPOSE: To evaluate the effects of a novel mouthrinse containing 0.07% high bioavailable cetylpyridinium chloride (Crest Pro-Health Rinse) on the development of gingivitis and plaque versus a placebo control over a period of 6 months. METHODS: This was a randomized, 6-month, placebo-controlled, parallel groups, double blind, single center clinical trial. One hundred thirty-nine generally healthy adults with mild-to-moderate gingivitis were enrolled in the study. Subjects were given Modified Gingival Index (MGI), Gingival Bleeding Index (GBI) and Modified Quigley-Hein Plaque Index (MQH) examinations followed by a dental prophylaxis. Subjects were then randomly assigned to either the cetylpyridinium chloride (CPC) rinse or placebo rinse and instructed to begin rinsing twice a day with 20 ml of their assigned mouthrinse for 30 seconds after brushing their teeth. Subjects were assessed for MGI, GBI and MQH scores after 3 and 6 months of product use. Oral hard and soft tissue examinations were also performed at all visits. RESULTS: 124 subjects were evaluable at Month 3 and 119 at Month 6. After 6 months, subjects rinsing with the CPC rinse showed 15.4% less gingival inflammation, 33.3% less gingival bleeding, and 15.8% less plaque relative to the placebo group. All reductions were highly statistically significantly different (P< 0.01). Results were similar at 3 months. Both treatments were well-tolerated. CLINICAL SIGNIFICANCE: This study demonstrates that the Crest Pro-Health 0.07% CPC mouthrinse provided significant antiplaque and antigingivitis benefits when used twice daily for 6 months as an adjunct to toothbrushing.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Cetilpiridínio/uso terapêutico , Placa Dentária/prevenção & controle , Gengivite/prevenção & controle , Antissépticos Bucais/uso terapêutico , Adolescente , Adulto , Idoso , Índice de Placa Dentária , Método Duplo-Cego , Feminino , Seguimentos , Hemorragia Gengival/prevenção & controle , Humanos , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/efeitos dos fármacos , Índice Periodontal , Placebos
6.
Quintessence Int ; 36(3): 209-27, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15887507

RESUMO

Cardiovascular diseases are the leading cause of death in the United States and most other Western countries. In the United States alone, more than 1 million annual deaths and as many as three times that number of serious consequences can be attributed to these conditions. To provide care to patients with cardiovascular disease, oral health care providers must understand the disease, its treatment, and its impact on the patient's ability to undergo and respond to dental care.


Assuntos
Doenças Cardiovasculares/complicações , Assistência Odontológica para Doentes Crônicos , Fármacos Cardiovasculares/uso terapêutico , Cárie Dentária/prevenção & controle , Hiperplasia Gengival/complicações , Gengivite/prevenção & controle , Humanos , Líquen Plano/complicações , Marca-Passo Artificial , Doenças Periodontais/complicações , Medição de Risco , Xerostomia/complicações , Xerostomia/prevenção & controle
7.
Quintessence Int ; 36(2): 119-37, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15732548

RESUMO

The heart pumps blood through a system of blood vessels under the control of an electric conduction system to deliver oxygen to all cells of the body. When the blood volume becomes greater than the limited volume capacity of the vascular system, the patient develops hypertension. When the myocardium does not get enough oxygen because of coronary artery disease, the patient will experience angina pectoris. If oxygen deprivation to the myocardium persists, the patient may develop myocardial infarction. When the conduction system malfunctions, arrhythmias occur and the heart is unable to pump blood through the vascular system at a regular rate and rhythm. When the heart is no longer able to pump enough blood to meet the metabolic demands of the body for oxygen, the patient is said to have developed heart failure. In addition, many of the above conditions can lead to thromboembolic complications. These cardiovascular diseases are the leading cause of death in the United States and most other Western countries. In the United States alone, more than 1 million annual deaths and as many as three times that number of serious consequences can be attributed to these conditions. To provide care to patients with cardiovascular disease, oral health care providers must understand the disease, its treatment, and its impact on the patient's ability to undergo and respond to dental care.


Assuntos
Doenças Cardiovasculares , Assistência Odontológica para Doentes Crônicos , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/terapia , Humanos , Medição de Risco , Estados Unidos/epidemiologia
8.
J Contemp Dent Pract ; 6(4): 1-16, 2005 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-16299602

RESUMO

North Americans in 2004 were projected to die from oral and pharyngeal cancer at a rate of 1.2 per hour. Oral healthcare providers can be instrumental in reducing the incidence of oral and pharyngeal premalignant and malignant lesions by identifying patients with high-risk behavior, educating their patients about the consequences of their high-risk behavior, and by early detection of premalignant and malignant conditions. The fact only 34% of the cancers of the oral cavity and larynx are localized at the time of diagnosis and evidence that at least one third of the patients diagnosed with an oral or pharyngeal malignancy have undergone oral cancer screening within the past three years suggests the current protocol for the early detection of pre-malignant or malignant changes appears to be deficient. To facilitate early diagnosis, oral healthcare providers must take into consideration the capriciousness of oral cancer and must be familiar with the availability and application of diagnostic modalities beyond conventional visual inspection and palpation of oral soft tissues. This article provides a comprehensive review of the disease for healthcare professionals.


Assuntos
Carcinoma de Células Escamosas , Neoplasias Bucais , Lesões Pré-Cancerosas/patologia , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/etiologia , Carcinoma de Células Escamosas/terapia , Assistência Odontológica para Doentes Crônicos , Diagnóstico Precoce , Eritroplasia/patologia , Humanos , Leucoplasia Oral/patologia , Líquen Plano Bucal/patologia , Neoplasias Bucais/diagnóstico , Neoplasias Bucais/epidemiologia , Neoplasias Bucais/etiologia , Neoplasias Bucais/terapia , Lesões Pré-Cancerosas/etiologia , Nicotiana/efeitos adversos , Estados Unidos/epidemiologia
9.
J Contemp Dent Pract ; 6(3): 1-13, 2005 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-16127467

RESUMO

OBJECTIVE: The objective of this study was to compare the plaque removal efficacy of a prototype manual Deep Clean toothbrush versus an American Dental Association (ADA) manual toothbrush and the ADA manual toothbrush in conjunction with floss. METHODS: This study was a randomized, examiner-blind, six-period cross-over, single-center study conducted in 60 adult subjects that examined plaque removal with a prototype Deep Clean manual toothbrush, an ADA reference manual toothbrush, and an ADA reference manual toothbrush followed by floss. During the course of this study, subjects used each treatment two times. Plaque was scored before and after brushing using the Rustogi Modification of the Navy Plaque Index. A mixed model analysis of covariance (ANCOVA) for a crossover design with baseline plaque score as the covariate was applied to the baseline minus one-minute post-brushing differences in average whole-mouth plaque scores. Supplemental analyses were also performed using the ANCOVA model separately for average gingival margin scores and for average interproximal scores, using the appropriate baseline score as the covariate. All comparisons were two-sided at the 0.05 level of significance. RESULTS: The prototype Deep Clean manual toothbrush delivered an adjusted (via ANCOVA) mean difference between baseline and post-brushing plaque scores of 0.245, while the ADA manual toothbrush plus floss delivered an adjusted mean difference of 0.207 versus 0.196 for the ADA manual toothbrush alone. The prototype Deep Clean manual toothbrush demonstrated a statistically significantly greater reduction in plaque than the ADA manual toothbrush plus floss (p<0.001), which in turn had a statistically significantly greater reduction in plaque than the ADA manual toothbrush alone (p<0.001). The prototype Deep Clean manual toothbrush group had, on average, 25.2% and 18.3% greater plaque removal scores than the ADA manual toothbrush alone and the ADA manual toothbrush plus floss groups, respectively. Results for the interproximal and gingival margin regions also demonstrated statistically significantly (p<0.001) greater plaque removal for the prototype Deep Clean manual toothbrush group relative to the other groups. CONCLUSIONS: The prototype manual Deep Clean toothbrush was found to deliver greater plaque removal by 25.2% and 18.3% compared to the control manual toothbrush group (ADA reference manual toothbrush) and ADA manual toothbrush plus floss group.


Assuntos
Dispositivos para o Cuidado Bucal Domiciliar , Placa Dentária/terapia , Escovação Dentária/instrumentação , Adulto , American Dental Association , Análise de Variância , Estudos Cross-Over , Índice de Placa Dentária , Humanos , Pessoa de Meia-Idade , Método Simples-Cego , Estados Unidos
10.
Quintessence Int ; 35(5): 378-84, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15130078

RESUMO

Population-based oral cancer screening appears to be a promising health promotion strategy (especially in high-risk individuals) with significant increases in quality-adjusted life years saved. However, the current protocol, conventional visual inspection, and palpation of oral soft tissues for the early detection of pre-malignant or malignant changes, appears to be deficient. The adjunctive application of technology to highlight such lesions may increase the diagnostic yield. The purpose of this pilot study was to collect data, which might support the hypothesis that oral soft tissues exhibit features similar to the cervical epithelium following an acetic acid wash and visual inspection under chemiluminescent illumination. The data provides strong evidence to support the hypothesis. Epithelium with hyperkeratinization, hyperparakeratinization, and/or chronic inflammatory infiltrate reflects the diffuse, low-level, blue-white chemiluminescent light more strongly and appears amplified. Similarly, epithelium with an altered nuclear-cytoplasmic ratio also reflects the diffuse, low-level, blue-white chemiluminescent light. In such cases, the lesions become clinically discernible and appear "acetowhite." Large-scale studies are required to further refine issues related to the selectivity and specificity of the technology.


Assuntos
Ácido Acético , Mucosa Bucal/patologia , Neoplasias Bucais/diagnóstico , Lesões Pré-Cancerosas/diagnóstico , Adolescente , Adulto , Idoso , Núcleo Celular/ultraestrutura , Citoplasma/ultraestrutura , Epitélio/patologia , Feminino , Humanos , Hiperplasia , Indicadores e Reagentes , Queratinas , Leucoplasia Oral/diagnóstico , Medições Luminescentes , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Sensibilidade e Especificidade
11.
Pediatr Dent ; 25(6): 541-5, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14733467

RESUMO

PURPOSE: Child abuse is a disturbingly common finding in society today. There have been substantial and significant increases in the incidence of child abuse since the last national incidence study was conducted in 1986. Kassebaum first reported the under-reporting of child abuse by Texas dental professionals in a survey in 1986. The objective of the current study was twofold: (1) assess the level of knowledge and attitudes among dental professionals on the important issue of child abuse; (2) evaluate and compare the results of the current study with a similar survey conducted in 1986. METHODS: A 24-question survey similar in format and content to the 1986 questionnaire was mailed to 1,046 Texas dentists, randomly selected from a membership roster provided by the Texas Dental Association. Both general dentists and selected specialists were included in the study group. The questionnaire consisted of multiple-choice and dichotomous yes/no questions. RESULTS: There were 383 responses to the questionnaire, yielding a response rate of 38%. The majority (N=289) of the respondents were general dentists. In answering questions about suspected and reported cases of child abuse, nearly 50% of the responding dentists reported they had suspected at least 1 case of child abuse. In the 1986 study, only 36% of the responding dentists reported they had suspected at least 1 case of child abuse. Between 1986 and 2001, the survey has shown that the percentage of dentists who reported at least 1 case to authorities slightly increased from 19% in 1986 to 25% in 2001, but the ratio of suspected to reported cases had not changed since 1986. CONCLUSIONS: Although the composite percentage of suspecting and reporting cases of child abuse from this survey is higher than the percentage demonstrated in 1986 study, there was no significant change in the relative ratio of reported cases to suspected cases in both surveys. This indicates that under-reporting of child abuse cases is still a significant problem in the dental profession in Texas.


Assuntos
Maus-Tratos Infantis/estatística & dados numéricos , Odontólogos/estatística & dados numéricos , Revelação/estatística & dados numéricos , Adulto , Idoso , Atitude do Pessoal de Saúde , Criança , Odontólogos/psicologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Responsabilidade Social , Inquéritos e Questionários , Texas
12.
J Contemp Dent Pract ; 5(2): 1-13, 2004 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-15150630

RESUMO

Vitamins are essential to maintain normal metabolic processes and homeostasis within the body. The amount of a specific vitamin required by an individual varies considerably and it is influenced by such factors as body size, growth rate, physical activity, and pregnancy. Most vitamins are stored minimally in human cells, but some are stored in liver cells to a greater extent. Vitamins A and D, for example, may be stored in sufficient amounts to maintain an individual without any intake for 5 to 10 months and 2 to 4 months, respectively. However, a deficiency of vitamin B compounds (except vitamin B12) may be noted within days, and the lack of vitamin C will manifest within weeks and may result in death in 5 to 6 months. The current recommended dietary allowance (RDA) of vitamin C is 75 mg for woman and 90 mg for men, based on the vitamin's role as an antioxidant as well as protection from deficiency. High intakes of the vitamin are generally well tolerated, however, a Tolerable Upper Level (TUL) was recently set at 2 g based on gastrointestinal upset that sometimes accompanies excessive dosages. Several populations warrant special attention with respect to vitamin C requirements. These include patients with periodontal disease, smokers, pregnant and lactating women, and the elderly.


Assuntos
Antioxidantes/farmacologia , Deficiência de Ácido Ascórbico/complicações , Ácido Ascórbico/farmacologia , Doenças Periodontais/etiologia , Doença de Alzheimer/prevenção & controle , Animais , Antioxidantes/administração & dosagem , Ácido Ascórbico/administração & dosagem , Regeneração Óssea/efeitos dos fármacos , Doenças Cardiovasculares/prevenção & controle , Condrogênese/efeitos dos fármacos , Diabetes Mellitus/tratamento farmacológico , Feminino , Humanos , Masculino , Dose Máxima Tolerável , Política Nutricional , Gravidez , Viroses/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA